Improving the process of hydrogenating organic compounds for drug development

Heterogeneous Directed Hydrogenation of Arenes and Olefins with Chemo- and Stereoselectivity

['FUNDING_OTHER'] · PURDUE UNIVERSITY · NIH-11087666

This study is exploring new ways to make important ingredients for medicines by using special materials that help create better and more effective drugs, which could mean better treatments for patients with fewer side effects.

Quick facts

Phase['FUNDING_OTHER']
Study typeNih_funding
SexAll
SponsorPURDUE UNIVERSITY (nih funded)
Locations1 site (WEST LAFAYETTE, UNITED STATES)
Trial IDNIH-11087666 on ClinicalTrials.gov

What this research studies

This research focuses on enhancing the hydrogenation process of unsaturated organic compounds, which is crucial for developing new pharmaceuticals. By using innovative bimetallic alloy catalysts, the project aims to achieve better selectivity and stereochemistry in these reactions. The approach involves directing the reactivity of the catalysts to improve the structural diversity of drug-like compounds, potentially leading to more effective medications. Patients may benefit from this research as it could lead to the development of new drugs with improved efficacy and fewer side effects.

Who could benefit from this research

Good fit: Ideal candidates for benefiting from this research are individuals who may require new or improved medications for various health conditions.

Not a fit: Patients who are not seeking new drug therapies or those with conditions that do not require pharmaceutical intervention may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to the creation of more effective and diverse pharmaceutical compounds.

How similar studies have performed: Previous research has shown promise in using directed reactivity with bimetallic catalysts, indicating potential for success in this novel approach.

Where this research is happening

WEST LAFAYETTE, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.